RecruitingPhase 2NCT07430046

Repurposing Mirtazapine in Rett Syndrome

Studying Rett syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Trieste
Principal Investigator
Enrico Tongiorgi, PhD, MD
University of Trieste, Trieste - Italy
Intervention
mirtazapine(drug)
Enrollment
54 enrolled
Eligibility
5-40 years · FEMALE
Timeline
20252026

Study locations (4)

Collaborators

Policlinico G . Martino, Messina Italy · IRCSS Gianna Gaslini, Genova, Italy · Policlinico S.Maria alle Scotte, Siena, Italy · ASST Ospedale Santi Paolo e Carlo, Milano, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07430046 on ClinicalTrials.gov

Other trials for Rett syndrome

Additional recruiting or active studies for the same condition.

See all trials for Rett syndrome

← Back to all trials